Fennec Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FENC and other ETFs, options, and stocks.

About FENC

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. 

CEO
Rostislav C. Raykov
CEORostislav C. Raykov
Employees
29
Employees29
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
1996
Founded1996
Employees
29
Employees29

FENC Key Statistics

Market cap
246.79M
Market cap246.79M
Price-Earnings ratio
-15.05
Price-Earnings ratio-15.05
Dividend yield
—
Dividend yield—
Average volume
142.61K
Average volume142.61K
High today
$9.31
High today$9.31
Low today
$8.99
Low today$8.99
Open price
$9.20
Open price$9.20
Volume
73.25K
Volume73.25K
52 Week high
$11.92
52 Week high$11.92
52 Week low
$6.30
52 Week low$6.30

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.